Search results
Showing 81 to 90 of 180 search results for guidance set out in Primary Market Bulletin No.
-
GC16/3: Primary Market Bulletin No. 13
GC16/3: Primary Market Bulletin No. 13. Newsletters First published:. 29/03/2016. Last updated: 03/09/2016. ... Additional powers to supervise and discipline sponsors (UKLA/TN/712.2). We summarise our proposals in Primary Market Bulletin No. -
FS22/4: ESG integration in UK capital markets
We summarise feedback to our discussion chapter (in CP21/18) on environmental, social and governance (ESG) integration in UK capital markets and set out our potential next steps. -
FSA - Primary Market Bulletin No.4: Summary of actions [pdf]
As explained in PMB No. 2, the UKLA Knowledge Base is our new online repository for formal guidance notes, offering practitioners guidance on a number of aspects of the Listing Rules (LR), the Prospectus Rules (PR) and the Disclosure and -
FSA - Primary Market Bulletin No.4: Text amended [pdf]
The listing and prospectus regimes are separate. An issuer who requires its securities to be admitted to the Official List maintained by the UKLA must apply to us for those securities to be listed. The issuer must then meet whichever set of listing -
The sponsor regime
Sponsors are firms we approve to advise premium listed companies on their obligations under the listing regime. Read more about the regime and being a sponsor. -
FAMR Baseline tracking
The Financial Advice Market Review (FAMR) Baseline Report sets out a range of indicators developed to give us a snapshot of the market for financial advice. In line with our commitment to monitor changes in the market, we publish follow-up consumer -
Primary Markets enforcement outcomes
A list of recent Primary Markets enforcement outcomes. -
Authorisation
Authorisation landing page -
Policy development update
The policy development update provides some information on our recent and upcoming publications but should not be regarded as comprehensive. -
Primary Market Bulletin Issue No. 27 – Coronavirus update
This is a special edition in which we provide key commentary for issuers and market participants in light of the coronavirus (Covid-19) pandemic.